{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:47:06Z","timestamp":1781531226857,"version":"3.54.5"},"reference-count":45,"publisher":"Sociedade Brasileira de Cardiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,25]]},"DOI":"10.36660\/abc.20210463","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T20:09:18Z","timestamp":1652731758000},"source":"Crossref","is-referenced-by-count":9,"title":["Aumento de Capta\u00e7\u00e3o Card\u00edaca de 18F-FDG Induzida por Quimioterapia em Pacientes com Linfoma: Um Marcador Precoce de Cardiotoxicidade?"],"prefix":"10.36660","author":[{"given":"Mayara L. C.","family":"Dourado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9893-4343","authenticated-orcid":false,"given":"Luca T.","family":"Dompieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauber M.","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A.","family":"Mourato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata G. G.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3584-5316","authenticated-orcid":false,"suffix":"Filho","given":"Paulo J","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3068-0540","authenticated-orcid":false,"suffix":"Filho","given":"Brivaldo","family":"Markman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-8783","authenticated-orcid":false,"given":"Marcelo D. T.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-1612","authenticated-orcid":false,"given":"Simone C. S.","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22636","reference":[{"issue":"4","key":"key20220516160913_B1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.currproblcancer.2018.05.005","article-title":"Advanced Imaging Modalities to Detect Cardiotoxicity","volume":"42","author":"Awadalla","year":"2018","unstructured":"1. Awadalla M, Hassan MZO, Alvi RM, Neilan TG. Advanced Imaging Modalities to Detect Cardiotoxicity. Curr Probl Cancer. 2018;42(4):386-96. doi: 10.1016\/j.currproblcancer.2018.05.005.","journal-title":"Curr Probl Cancer"},{"issue":"2","key":"key20220516160913_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0066-782X2011000700001","article-title":"I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia","volume":"96","author":"Kalil","year":"2011","unstructured":"2. Kalil Filho R, Hajjar LA, Bacal F, Hoff PM, Diz MP, Galas FR, et al. I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2011;96(2 Suppl 1):1-52.","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"key20220516160913_B3","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-017-0846-x","article-title":"Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions","volume":"19","author":"Jain","year":"2017","unstructured":"3. Jain D, Russell RR, Schwartz RG, Panjrath GS, Aronow W. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions. Curr Cardiol Rep. 2017;19(5):36. doi: 10.1007\/s11886-017-0846-x.","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"key20220516160913_B4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","article-title":"Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience","volume":"20","author":"Seidman","year":"2002","unstructured":"4. Seidman A, Hudis C, Pierri MK, Shak S, Paton V, Ashby M, et al. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience. J Clin Oncol. 2002;20(5):1215-21. doi: 10.1200\/JCO.2002.20.5.1215.","journal-title":"J Clin Oncol"},{"key":"key20220516160913_B5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/annonc\/mds293","article-title":"Cardiovascular Toxicity Induced by Chemotherapy, Targeted Agents and Radiotherapy: ESMO Clinical Practice Guidelines","volume":"23","author":"Curigliano","year":"2012","unstructured":"5. Curigliano G, Cardinale D, Suter T, Plataniotis G, Azambuja E, Sandri MT, et al. Cardiovascular Toxicity Induced by Chemotherapy, Targeted Agents and Radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(Suppl 7):155-66. doi: 10.1093\/annonc\/mds293.","journal-title":"Ann Oncol"},{"issue":"1","key":"key20220516160913_B6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12574-017-0344-6","article-title":"Echocardiographic Evaluation of Cardiac Function After Cancer Chemotherapy","volume":"16","author":"Negishi","year":"2018","unstructured":"6. Negishi T, Negishi K. Echocardiographic Evaluation of Cardiac Function After Cancer Chemotherapy. J Echocardiogr. 2018;16(1):20-7. doi: 10.1007\/s12574-017-0344-6.","journal-title":"J Echocardiogr"},{"issue":"1","key":"key20220516160913_B7","article-title":"Rationale for Setting up a Cardio-Oncology Unit: Our Experience at Mayo Clinic","volume":"2","author":"Barros-Gomes","year":"2016","unstructured":"7. Barros-Gomes S, Herrmann J, Mulvagh SL, Lerman A, Lin G, Villarraga HR. Rationale for Setting up a Cardio-Oncology Unit: Our Experience at Mayo Clinic. Cardiooncology. 2016;2(1):5. doi: 10.1186\/s40959-016-0014-2.","journal-title":"Cardiooncology"},{"issue":"15","key":"key20220516160913_B8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy","volume":"342","author":"Felker","year":"2000","unstructured":"8. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy. N Engl J Med. 2000;342(15):1077-84. doi: 10.1056\/NEJM200004133421502.","journal-title":"N Engl J Med"},{"issue":"18","key":"key20220516160913_B9","first-page":"1","article-title":"New Imaging Methods for Detection of Drug-Induced Cardiotoxicity in Cancer Patients","volume":"10","author":"Simoni","year":"2017","unstructured":"9. Simoni LJC, Brand\u00e3o SCS. New Imaging Methods for Detection of Drug-Induced Cardiotoxicity in Cancer Patients. Curr Cardiovasc Imaging Rep. 2017;10(18):1-11. doi: 10.1007\/s12410-017-9415-3.","journal-title":"Curr Cardiovasc Imaging Rep"},{"issue":"3","key":"key20220516160913_B10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11307-019-01417-3","article-title":"Assessment of Chemotherapy-Induced Organ Damage with Ga-68 Labeled Duramycin","volume":"22","author":"Rix","year":"2020","unstructured":"10. Rix A, Drude NI, Mrugalla A, Baskaya F, Pak KY, Gray B, et al. Assessment of Chemotherapy-Induced Organ Damage with Ga-68 Labeled Duramycin. Mol Imaging Biol. 2020;22(3):623-33. doi: 10.1007\/s11307-019-01417-3.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"key20220516160913_B11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12350-019-01655-6","article-title":"Nuclear Cardio-Oncology: From its Foundation to its Future","volume":"27","author":"Kahanda","year":"2020","unstructured":"11. Kahanda MG, Hanson CA, Patterson B, Bourque JM. Nuclear Cardio-Oncology: From its Foundation to its Future. J Nucl Cardiol. 2020;27(2):511-8. doi: 10.1007\/s12350-019-01655-6.","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"key20220516160913_B12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11307-017-1044-3","article-title":"The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy","volume":"19","author":"Wu","year":"2017","unstructured":"12. Wu X, Bhattarai A, Korkola P, Pertovaara H, Eskola H, Kellokumpu-Lehtinen PL. The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy. Mol Imaging Biol. 2017;19(5):787-94. doi: 10.1007\/s11307-017-1044-3.","journal-title":"Mol Imaging Biol"},{"key":"key20220516160913_B13","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.2147\/CMAR.S216445","article-title":"Prognostic Values of Baseline, Interim and End-of Therapy 18F-FDG PET\/CT in Patients with Follicular Lymphoma","volume":"11","author":"Zhou","year":"2019","unstructured":"13. Zhou Y, Zhao Z, Li J, Zhang B, Sang S, Wu Y, et al. Prognostic Values of Baseline, Interim and End-of Therapy 18F-FDG PET\/CT in Patients with Follicular Lymphoma. Cancer Manag Res. 2019;11:6871-85. doi: 10.2147\/CMAR.S216445.","journal-title":"Cancer Manag Res"},{"issue":"6","key":"key20220516160913_B14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11307-019-01314-9","article-title":"Anesthesia and Preconditioning Induced Changes in Mouse Brain [18F] FDG Uptake and Kinetics","volume":"21","author":"Bascu\u00f1ana","year":"2019","unstructured":"14. Bascu\u00f1ana P, Thackeray JT, Bankstahl M, Bengel FM, Bankstahl JP. Anesthesia and Preconditioning Induced Changes in Mouse Brain [18F] FDG Uptake and Kinetics. Mol Imaging Biol. 2019;21(6):1089-96. doi: 10.1007\/s11307-019-01314-9.","journal-title":"Mol Imaging Biol"},{"key":"key20220516160913_B15","doi-asserted-by":"crossref","DOI":"10.1038\/srep25092","article-title":"Discovery of a Novel Glucose Metabolism in Cancer: The Role of Endoplasmic Reticulum Beyond Glycolysis and Pentose Phosphate Shunt","volume":"6","author":"Marini","year":"2016","unstructured":"15. Marini C, Ravera S, Buschiazzo A, Bianchi G, Orengo AM, Bruno S, et al. Discovery of a Novel Glucose Metabolism in Cancer: The Role of Endoplasmic Reticulum Beyond Glycolysis and Pentose Phosphate Shunt. Sci Rep. 2016;6:25092. doi: 10.1038\/srep25092.","journal-title":"Sci Rep"},{"issue":"2","key":"key20220516160913_B16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0003-9861(03)00229-7","article-title":"Murine Hexose-6-Phosphate Dehydrogenase: A Bifunctional Enzyme with Broad Substrate Specificity and 6-Phosphogluconolactonase Activity","volume":"415","author":"Clarke","year":"2003","unstructured":"16. Clarke JL, Mason PJ. Murine Hexose-6-Phosphate Dehydrogenase: A Bifunctional Enzyme with Broad Substrate Specificity and 6-Phosphogluconolactonase Activity. Arch Biochem Biophys. 2003;415(2):229-34. doi: 10.1016\/s0003-9861(03)00229-7.","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"key20220516160913_B17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1179\/174329210X12650506623249","article-title":"Contribution of Hexose-6-Phosphate Dehydrogenase to NADPH Content and Redox Environment in the Endoplasmic reticulum","volume":"15","author":"Rogoff","year":"2010","unstructured":"17. Rogoff D, Black K, McMillan DR, White PC. Contribution of Hexose-6-Phosphate Dehydrogenase to NADPH Content and Redox Environment in the Endoplasmic reticulum. Redox Rep. 2010;15(2):64-70. doi: 10.1179\/174329210X12650506623249.","journal-title":"Redox Rep"},{"key":"key20220516160913_B18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00259-017-3687-3","article-title":"Evaluating Tumor Response with FDG PET: Updates on PERCIST, Comparison with EORTC Criteria and Clues to Future Developments","volume":"44","author":"Pinker","year":"2017","unstructured":"18. Pinker K, Riedl C, Weber WA. Evaluating Tumor Response with FDG PET: Updates on PERCIST, Comparison with EORTC Criteria and Clues to Future Developments. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):55-66. doi: 10.1007\/s00259-017-3687-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"key20220516160913_B19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1753944712474332","article-title":"Chemotherapy-related Cardiotoxicity","volume":"7","author":"Aggarwal","year":"2013","unstructured":"19. Aggarwal S, Kamboj J, Arora R. Chemotherapy-related Cardiotoxicity. Ther Adv Cardiovasc Dis. 2013;7(2):87-98. doi: 10.1177\/1753944712474332.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"6","key":"key20220516160913_B20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00280-013-2260-4","article-title":"The Role of Antioxidants in the Era of Cardio-Oncology","volume":"72","author":"Vincent","year":"2013","unstructured":"20. Vincent DT, Ibrahim YF, Espey MG, Suzuki YJ. The Role of Antioxidants in the Era of Cardio-Oncology. Cancer Chemother Pharmacol. 2013;72(6):1157-68. doi: 10.1007\/s00280-013-2260-4.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"key20220516160913_B21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the Molecular Basis of Doxorubicin-Induced Cardiotoxicity","volume":"18","author":"Zhang","year":"2012","unstructured":"21. Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, et al. Identification of the Molecular Basis of Doxorubicin-Induced Cardiotoxicity. Nat Med. 2012;18(11):1639-42. doi: 10.1038\/nm.2919.","journal-title":"Nat Med"},{"issue":"5","key":"key20220516160913_B22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2310\/7290.2010.00058","article-title":"In Vivo Imaging of Apoptosis in Oncology: An Update","volume":"10","author":"Vangestel","year":"2011","unstructured":"22. Vangestel C, Peeters M, Mees G, Oltenfreiter R, Boersma HH, Elsinga PH, et al. In Vivo Imaging of Apoptosis in Oncology: An Update. Mol Imaging. 2011;10(5):340-58. doi: 10.2310\/7290.2010.00058.","journal-title":"Mol Imaging"},{"issue":"8","key":"key20220516160913_B23","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-014-0396-y","article-title":"Cardiotoxicity of Antineoplastic Agents: What is the Present and Future Role for Imaging?","volume":"16","author":"Markman","year":"2014","unstructured":"23. Markman TM, Markman M. Cardiotoxicity of Antineoplastic Agents: What is the Present and Future Role for Imaging? Curr Oncol Rep. 2014;16(8):396. doi: 10.1007\/s11912-014-0396-y.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"key20220516160913_B24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/echo.12331","article-title":"Left Ventricular Ejection Fraction and Volumes: It Depends on the Imaging Method","volume":"31","author":"Wood","year":"2014","unstructured":"24. Wood PW, Choy JB, Nanda NC, Becher H. Left Ventricular Ejection Fraction and Volumes: It Depends on the Imaging Method. Echocardiography. 2014;31(1):87-100. doi: 10.1111\/echo.12331.","journal-title":"Echocardiography"},{"issue":"10","key":"key20220516160913_B25","first-page":"12216","article-title":"Effects of PPAR\u03b1\/PGC-1\u03b1 on the Energy Metabolism Remodeling and Apoptosis in the Doxorubicin Induced Mice Cardiomyocytes in Vitro","volume":"8","author":"Yang","year":"2015","unstructured":"25. Yang Y, Zhang H, Li X, Yang T, Jiang Q. Effects of PPAR\u03b1\/PGC-1\u03b1 on the Energy Metabolism Remodeling and Apoptosis in the Doxorubicin Induced Mice Cardiomyocytes in Vitro. Int J Clin Exp Pathol. 2015;8(10):12216-24.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"key20220516160913_B26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4329\/wjr.v4.i5.220","article-title":"Enhanced Myocardial Fluorodeoxyglucose Uptake Following Adriamycin-Based Therapy: Evidence of Early Chemotherapeutic Cardiotoxicity?","volume":"4","author":"Borde","year":"2012","unstructured":"26. Borde C, Kand P, Basu S. Enhanced Myocardial Fluorodeoxyglucose Uptake Following Adriamycin-Based Therapy: Evidence of Early Chemotherapeutic Cardiotoxicity? World J Radiol. 2012;4(5):220-3. doi: 10.4329\/wjr.v4.i5.220.","journal-title":"World J Radiol"},{"issue":"1","key":"key20220516160913_B27","doi-asserted-by":"crossref","first-page":"e0169964","DOI":"10.1371\/journal.pone.0169964","article-title":"A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate","volume":"12","author":"O\u2019Farrell","year":"2017","unstructured":"27. O\u2019Farrell AC, Evans R, Silvola JM, Miller IS, Conroy E, Hector S, et al. A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate. PLoS One. 2017;12(1):e0169964. doi: 10.1371\/journal.pone.0169964.","journal-title":"PLoS One"},{"issue":"11","key":"key20220516160913_B28","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.19551","article-title":"Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is Rescued by Endothelin Receptor Antagonism","volume":"7","author":"Sourdon","year":"2017","unstructured":"28. Sourdon J, Lager F, Viel T, Balvay D, Moorhouse R, Bennana E, et al. Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is Rescued by Endothelin Receptor Antagonism. Theranostics. 2017;7(11):2757-74. doi: 10.7150\/thno.19551.","journal-title":"Theranostics"},{"issue":"6","key":"key20220516160913_B29","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s12350-019-01617-y","article-title":"Association Between FDG Uptake in the Right Ventricular Myocardium and Cancer Therapy-Induced Cardiotoxicity","volume":"27","author":"Kim","year":"2020","unstructured":"29. Kim J, Cho SG, Kang SR, Yoo SW, Kwon SY, Min JJ, et al. Association Between FDG Uptake in the Right Ventricular Myocardium and Cancer Therapy-Induced Cardiotoxicity. J Nucl Cardiol. 2020;27(6):2154-63. doi: 10.1007\/s12350-019-01617-y.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"key20220516160913_B30","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1670-9","article-title":"An Increase in Myocardial 18-Fluorodeoxyglucose Uptake is Associated with Left Ventricular Ejection Fraction Decline in Hodgkin Lymphoma Patients Treated with Anthracycline","volume":"16","author":"Sarocchi","year":"2018","unstructured":"30. Sarocchi M, Bauckneht M, Arboscello E, Capitanio S, Marini C, Morbelli S, et al. An Increase in Myocardial 18-Fluorodeoxyglucose Uptake is Associated with Left Ventricular Ejection Fraction Decline in Hodgkin Lymphoma Patients Treated with Anthracycline. J Transl Med. 2018;16(1):295. doi: 10.1186\/s12967-018-1670-9.","journal-title":"J Transl Med"},{"issue":"10","key":"key20220516160913_B31","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.117.191122","article-title":"Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET\/CT Observation","volume":"58","author":"Bauckneht","year":"2017","unstructured":"31. Bauckneht M, Ferrarazzo G, Fiz F, Morbelli S, Sarocchi M, Pastorino F, et al. Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET\/CT Observation. J Nucl Med. 2017;58(10):1638-45. doi: 10.2967\/jnumed.117.191122.","journal-title":"J Nucl Med"},{"issue":"4","key":"key20220516160913_B32","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics7040057","article-title":"A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility","volume":"7","author":"Bauckneht","year":"2017","unstructured":"32. Bauckneht M, Morbelli S, Fiz F, Ferrarazzo G, Piva R, Nieri A, et al. A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility. Diagnostics. 2017;7(4):57 doi: 10.2967\/jnumed.117.191122.","journal-title":"Diagnostics"},{"issue":"6","key":"key20220516160913_B33","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s12350-019-01618-x","article-title":"Increased Myocardial 18F-FDG Uptake as a Marker of Doxorubicin-Induced Oxidative Stress","volume":"27","author":"Bauckneht","year":"2020","unstructured":"33. Bauckneht M, Pastorino F, Castellani P, Cossu V, Orengo AM, Piccioli P, et al. Increased Myocardial 18F-FDG Uptake as a Marker of Doxorubicin-Induced Oxidative Stress. J Nucl Cardiol. 2020;27(6):2183-94. doi: 10.1007\/s12350-019-01618-x.","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"key20220516160913_B34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-Induced Cardiomyopathy: from Molecular Mechanisms to Therapeutic Strategies","volume":"52","author":"Octavia","year":"2012","unstructured":"34. Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-Induced Cardiomyopathy: from Molecular Mechanisms to Therapeutic Strategies. J Mol Cell Cardiol. 2012;52(6):1213-25. doi: 10.1016\/j.yjmcc.2012.03.006.","journal-title":"J Mol Cell Cardiol"},{"issue":"26","key":"key20220516160913_B35","doi-asserted-by":"crossref","first-page":"27017","DOI":"10.1074\/jbc.M404159200","article-title":"Cooperativity Between 11beta-Hydroxysteroid Dehydrogenase type 1 and Hexose-6-Phosphate Dehydrogenase in the Lumen of the Endoplasmic Reticulum","volume":"279","author":"B\u00e1nhegyi","year":"2004","unstructured":"35. B\u00e1nhegyi G, Benedetti A, Fulceri R, Senesi S. Cooperativity Between 11beta-Hydroxysteroid Dehydrogenase type 1 and Hexose-6-Phosphate Dehydrogenase in the Lumen of the Endoplasmic Reticulum. J Biol Chem. 2004;279(26):27017-21. doi: 10.1074\/jbc.M404159200.","journal-title":"J Biol Chem"},{"issue":"8","key":"key20220516160913_B36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.cdd.4401420","article-title":"Glucose-6-Phosphate Dehydrogenase Plays a Crucial Role in Protection from Redox-Stress-Induced Apoptosis","volume":"11","author":"Fico","year":"2004","unstructured":"36. Fico A, Paglialunga F, Cigliano L, Abrescia P, Verde P, Martini G, et al. Glucose-6-Phosphate Dehydrogenase Plays a Crucial Role in Protection from Redox-Stress-Induced Apoptosis. Cell Death Differ. 2004;11(8):823-31. doi: 10.1038\/sj.cdd.4401420.","journal-title":"Cell Death Differ"},{"issue":"1","key":"key20220516160913_B37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/bcmd.1999.0224","article-title":"Human Hexose-6-Phosphate Dehydrogenase (glucose 1-dehydrogenase) Encoded at 1p36: Coding Sequence and Expression","volume":"25","author":"Mason","year":"1999","unstructured":"37. Mason PJ, Stevens D, Diez A, Knight SW, Scopes DA, Vulliamy TJ. Human Hexose-6-Phosphate Dehydrogenase (glucose 1-dehydrogenase) Encoded at 1p36: Coding Sequence and Expression. Blood Cells Mol Dis. 1999;25(1):30-7. doi: 10.1006\/bcmd.1999.0224.","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"key20220516160913_B38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0003-9861(03)00229-7","article-title":"Murine Hexose-6-Phosphate Dehydrogenase: A Bifunctional Enzyme with Broad Substrate Specificity and 6-Phosphogluconolactonase Activity","volume":"415","author":"Clarke","year":"2003","unstructured":"38. Clarke JL, Mason PJ. Murine Hexose-6-Phosphate Dehydrogenase: A Bifunctional Enzyme with Broad Substrate Specificity and 6-Phosphogluconolactonase Activity. Arch Biochem Biophys. 2003;415(2):229-34. doi: 10.1016\/s0003-9861(03)00229-7.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"key20220516160913_B39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.004796","article-title":"Glucose Regulation of Load-Induced mTOR Signaling and ER Stress in Mammalian Heart","volume":"2","author":"Sen","year":"2013","unstructured":"39. Sen S, Kundu BK, Wu HC, Hashmi SS, Guthrie P, Locke LW, et al. Glucose Regulation of Load-Induced mTOR Signaling and ER Stress in Mammalian Heart. J Am Heart Assoc. 2013;2(3):e004796. doi: 10.1161\/JAHA.113.004796.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"key20220516160913_B40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2967\/jnumed.112.108092","article-title":"Quantitative PET Imaging Detects Early Metabolic Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy in Vivo","volume":"54","author":"Zhong","year":"2013","unstructured":"40. Zhong M, Alonso CE, Taegtmeyer H, Kundu BK. Quantitative PET Imaging Detects Early Metabolic Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy in Vivo. J Nucl Med. 2013;54(4):609-15. doi: 10.2967\/jnumed.112.108092.","journal-title":"J Nucl Med"},{"issue":"1-2","key":"key20220516160913_B41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0005-2736(02)00612-0","article-title":"Doxorubicin Induces Early Lipid Peroxidation Associated with Changes in Glucose Transport in Cultured Cardiomyocytes","volume":"1567","author":"Hrelia","year":"2002","unstructured":"41. Hrelia S, Fiorentini D, Maraldi T, Angeloni C, Bordoni A, Biagi PL, et al. Doxorubicin Induces Early Lipid Peroxidation Associated with Changes in Glucose Transport in Cultured Cardiomyocytes. Biochim Biophys Acta. 2002;1567(1-2):150-6. doi: 10.1016\/s0005-2736(02)00612-0.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"key20220516160913_B42","first-page":"370","article-title":"EGFR Mutation Decreases FDG Uptake in Non-Small Cell Lung Cancer via the NOX4\/ROS\/GLUT1 Axis","volume":"54","author":"Chen","year":"2019","unstructured":"42. Chen L, Zhou Y, Tang X, Yang C, Tian Y, Xie R, et al. EGFR Mutation Decreases FDG Uptake in Non-Small Cell Lung Cancer via the NOX4\/ROS\/GLUT1 Axis. Int J Oncol. 2019;54(1):370-80. doi: 10.3892\/ijo.2018.4626.","journal-title":"Int J Oncol"},{"issue":"5","key":"key20220516160913_B43","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00259-018-4254-2","article-title":"Obligatory Role of Endoplasmic Reticulum in Brain FDG Uptake","volume":"46","author":"Cossu","year":"2019","unstructured":"43. Cossu V, Marini C, Piccioli P, Rocchi A, Bruno S, Orengo AM, et al. Obligatory Role of Endoplasmic Reticulum in Brain FDG Uptake. Eur J Nucl Med Mol Imaging. 2019;46(5):1184-96. doi: 10.1007\/s00259-018-4254-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"key20220516160913_B44","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-018-0398-0","article-title":"Effect of Starvation on Brain Glucose Metabolism and 18F-2-fluoro-2-deoxyglucose Uptake: An Experimental In-vivo and Ex-vivo Study","volume":"8","author":"Buschiazzo","year":"2018","unstructured":"44. Buschiazzo A, Cossu V, Bauckneht M, Orengo A, Piccioli P, Emionite L, et al. Effect of Starvation on Brain Glucose Metabolism and 18F-2-fluoro-2-deoxyglucose Uptake: An Experimental In-vivo and Ex-vivo Study. EJNMMI Res. 2018;8(1):44. doi: 10.1186\/s13550-018-0398-0.","journal-title":"EJNMMI Res"},{"key":"key20220516160913_B45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molmet.2019.11.007","article-title":"FDG Uptake Tracks the Oxidative Damage in Diabetic Skeletal Muscle: An Experimental Study","volume":"31","author":"Bauckneht","year":"2020","unstructured":"45. Bauckneht M, Cossu V, Castellani P, Piccioli P, Orengo AM, Emionite L, et al. FDG Uptake Tracks the Oxidative Damage in Diabetic Skeletal Muscle: An Experimental Study. Mol Metab. 2020;31:98-108. doi: 10.1016\/j.molmet.2019.11.007.","journal-title":"Mol Metab"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/aumento-de-captacao-cardiaca-de-18f-fdg-induzida-por-quimioterapia-em-pacientes-com-linfoma-um-marcador-precoce-de-cardiotoxicidade\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:09:20Z","timestamp":1747400960000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/aumento-de-captacao-cardiaca-de-18f-fdg-induzida-por-quimioterapia-em-pacientes-com-linfoma-um-marcador-precoce-de-cardiotoxicidade\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":45,"alternative-id":["10.36660\/abc.20210463"],"URL":"https:\/\/doi.org\/10.36660\/abc.20210463","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]}}}